{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T05:01:26Z","timestamp":1761541286369},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,10,24]],"date-time":"2015-10-24T00:00:00Z","timestamp":1445644800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Thromb Thrombolysis"],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1007\/s11239-015-1294-3","type":"journal-article","created":{"date-parts":[[2015,10,24]],"date-time":"2015-10-24T14:18:51Z","timestamp":1445696331000},"page":"90-98","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Nadroparin for the prevention of venous thromboembolism in nonsurgical patients: a systematic review and meta-analysis"],"prefix":"10.1007","volume":"42","author":[{"given":"Walter","family":"Ageno","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacqueline","family":"Bosch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michel","family":"Cucherat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John W.","family":"Eikelboom","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,10,24]]},"reference":[{"key":"1294_CR1","doi-asserted-by":"crossref","first-page":"e195S","DOI":"10.1378\/chest.11-2296","volume":"141","author":"SR Kahn","year":"2012","unstructured":"Kahn SR, Lim W, Dunn AS (2012) Prevention of VTE in nonsurgical patients: antithrombotic therapy and prevention of thrombosis, 9th ed: American college of Chest Physicians evidence-based clinical practice guidelines. Chest 141:e195S\u2013e226S","journal-title":"Chest"},{"issue":"339","key":"1294_CR2","doi-asserted-by":"crossref","first-page":"b2535","DOI":"10.1136\/bmj.b2535","volume":"2009","author":"D Moher","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG, The PRISMA Group (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ 2009(339):b2535. doi: 10.1136\/bmj.b2535","journal-title":"BMJ"},{"key":"1294_CR3","unstructured":"Higgins JPT, Green S (eds) (2011) Cochrane handbook for systematic reviews of interventions version 5.1.0 [updated March 2011]. The Cochrane Collaboration. www.cochrane-handbook.org"},{"key":"1294_CR4","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/sim.1186","volume":"21","author":"JP Higgins","year":"2002","unstructured":"Higgins JP, Thompson SG (2002) Quantifying heterogeneity in a meta-analysis. Stat Med 21:1539\u20131558","journal-title":"Stat Med"},{"key":"1294_CR5","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/S1470-2045(09)70232-3","volume":"10","author":"G Agnelli","year":"2009","unstructured":"Agnelli G, Gussoni G, Bianchini C, Verso M, Mandal\u00e0 M, Cavanna L, Barni S, Labianca R, Buzzi F, Scambia G, Passalacqua R, Ricci S, Gasparini G, Lorusso V, Bonizzoni E, Tonato M (2009) Nadroparin for the prevention of thromboembolic events in ambulatory patients with metastatic or locally advanced solid cancer receiving chemotherapy: a randomised, placebo-controlled, double-blind study. Lancet Oncol 10:943\u2013949","journal-title":"Lancet Oncol"},{"key":"1294_CR6","unstructured":"Aquino J-P, Gambier A, Ducros JJ (1990) Book: prevention of thromboembolic accidents in elderly subjects with nadroparin. In: Bounameaux H, Samama M, ten Cate JW (eds) Fraxiparine, Second International Symposium. Schattauer, New York. pp 51\u20134"},{"key":"1294_CR7","first-page":"567","volume":"24","author":"B Forette","year":"1995","unstructured":"Forette B, Wolmark Y (1995) Calcium nadroparin in the prevention of thromboembolic disease in elderly subjects. Study of tolerance. Presse Med 24:567\u2013571","journal-title":"Presse Med"},{"key":"1294_CR8","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1164\/ajrccm.161.4.9807025","volume":"161","author":"F Fraisse","year":"2000","unstructured":"Fraisse F, Holzapfel L, Couland JM, Simonneau G, Bedock B, Feissel M, Herbecq P, Pordes R, Poussel JF, Roux L (2000) Nadroparin in the prevention of deep vein thrombosis in acute decompensated COPD. The Association of Non-University Affiliated Intensive Care Specialist Physicians of France. Am J Respir Crit Care Med 161:1109\u20131114","journal-title":"Am J Respir Crit Care Med"},{"key":"1294_CR9","first-page":"127","volume":"26","author":"J Harenberg","year":"1996","unstructured":"Harenberg J, Roebruck P, Heene DL (1996) Subcutaneous low-molecular-weight heparin versus standard heparin and the prevention of thromboembolism in medical inpatients. The Heparin Study in Internal Medicine Group. Haemostasis 26:127\u2013139","journal-title":"Haemostasis"},{"issue":"Suppl 1","key":"1294_CR10","first-page":"20","volume":"23","author":"P Kujath","year":"1993","unstructured":"Kujath P, Spannagel U (1993) Habscheid W Incidence and prophylaxis of deep venous thrombosis in outpatients with injury of the lower limb. Haemostasis 23(Suppl 1):20\u201326","journal-title":"Haemostasis"},{"key":"1294_CR11","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s00228-005-0944-3","volume":"61","author":"I Mah\u00e9","year":"2005","unstructured":"Mah\u00e9 I, Bergmann JF, d\u2019Az\u00e9mar P, Vaissie JJ (2005) Caulin C Lack of effect of a low-molecular-weight heparin (nadroparin) on mortality in bedridden medical in-patients: a prospective randomised double-blind study. Eur J Clin Pharmacol 61:347\u2013351","journal-title":"Eur J Clin Pharmacol"},{"key":"1294_CR12","unstructured":"Manciet G., Vergnes C, Vaissi\u00e9 JJ, et al. (1990) Book: A study on the efficacy and tolerance of Fraxiparine during long-term therapy of the elderly. In: Bounameaux H, Samama M, ten Cate JW (eds) Fraxiparine, Second International Symposium. Schattauer, New York, pp 55\u201362"},{"key":"1294_CR13","first-page":"67","volume":"88","author":"P Mismetti","year":"2003","unstructured":"Mismetti P, Mille D, Laporte S, Charlet V, Buchm\u00fcller-Cordier A, Jacquin JP, Fournel P, Dutrey-Dupagne C (2003) Decousus H Low-molecular-weight heparin (nadroparin) and very low doses of warfarin in the prevention of upper extremity thrombosis in cancer patients with indwelling long-term central venous catheters: a pilot randomized trial. Haematologica 88:67\u201373","journal-title":"Haematologica"},{"key":"1294_CR14","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1111\/jth.12165","volume":"11","author":"CM Samama","year":"2013","unstructured":"Samama CM, Lecoules N, Kierzek G, Claessens YE, Riou B, Rosencher N, Mismetti P, Sautet A, Barrellier MT, Apartsin K, Jonas M, Caeiro JR, van der Veen AH, Roy PM (2013) Comparison of fondaparinux with low molecular weight heparin for venous thromboembolism prevention in patients requiring rigid or semi-rigid immobilization for isolated non-surgical below-knee injury. J Thromb Haemost 11:1833\u20131843","journal-title":"J Thromb Haemost"},{"key":"1294_CR15","doi-asserted-by":"crossref","first-page":"278","DOI":"10.7326\/0003-4819-146-4-200702200-00007","volume":"146","author":"F Dentali","year":"2007","unstructured":"Dentali F, Douketis JD, Gianni M, Lim W, Crowther MA (2007) Meta-analysis: anticoagulant prophylaxis to prevent symptomatic venous thromboembolism in hospitalized medical patients. Ann Intern Med 146:278\u2013288","journal-title":"Ann Intern Med"},{"key":"1294_CR16","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1055\/s-0037-1613749","volume":"83","author":"P Mismetti","year":"2000","unstructured":"Mismetti P, Laporte-Simitsidis S, Tardy B et al (2000) Prevention of venous thromboembolism in internal medicine with unfractionated or low-molecular-weight heparins: a meta-analysis of randomised clinical trials. Thromb Haemost 83:14\u201319","journal-title":"Thromb Haemost"},{"issue":"26","key":"1294_CR17","doi-asserted-by":"crossref","first-page":"2463","DOI":"10.1056\/NEJMoa1111288","volume":"365","author":"AK Kakkar","year":"2011","unstructured":"Kakkar AK, Cimminiello C, Goldhaber SZ, Parakh R, Wang C, Bergmann JF (2011) LIFENOX investigators. Low-molecular-weight heparin and mortality in acutely ill medical patients. N Engl J Med 365(26):2463\u20132472","journal-title":"N Engl J Med"}],"container-title":["Journal of Thrombosis and Thrombolysis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-015-1294-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11239-015-1294-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-015-1294-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,31]],"date-time":"2019-08-31T22:08:13Z","timestamp":1567289293000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11239-015-1294-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10,24]]},"references-count":17,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,7]]}},"alternative-id":["1294"],"URL":"https:\/\/doi.org\/10.1007\/s11239-015-1294-3","relation":{},"ISSN":["0929-5305","1573-742X"],"issn-type":[{"value":"0929-5305","type":"print"},{"value":"1573-742X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,10,24]]}}}